Skip to main content

CITADEL ADVISORS LLC

Position in ALMS — Alumis Inc.

CIK 1423053 MIAMI, FL

Position in ALMS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$7,743,698
+$6,579,223 QoQ
Shares Held
351,507
+194.6% QoQ
Ownership
0.276%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
7 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ALMS Over Time

Shares Held

Position Value (USD)

Derivatives in ALMS

reported options exposure · as of Mar 31, 2026
CallValue
$2,183,173
CallShares
99,100
PutValue
$2,623,773
PutShares
119,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,784,241,435 across 374 Biotechnology names. ALMS ranks #105 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ALMS

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,183,173 99,100
2026-03-31 $2,623,773 119,100
2026-03-31 $7,743,698 351,507
2025-12-31 $1,164,475 119,311
2025-12-31 $448,960 46,000
2025-12-31 $209,840 21,500
2025-09-30 $1,353,611 339,251
2025-09-30 $771,059 193,248
2025-09-30 $42,294 10,600
2025-06-30 $319,800 106,600
2025-06-30 $563,484 187,828
2025-06-30 $321,225 107,075
2024-12-31 $229,111 29,149
2024-09-30 $443,422 41,519
2024-06-30 $278,262 20,922